In this week’s Pharma Pulse, GoodRx expands an employer offering built on manufacturer pricing for GLP-1 obesity drugs, a ...
DOL's final rule requires PBMs to disclose rebates and formulary incentives to large self-insured plans for plan years ...
Why outdated paper prescribing information is creating unnecessary cost, complexity and friction across a modern ...
EVERSANA is folding Estima Scientific's AI-powered HEOR tools into its market access offerings as its CEO says evidence ...
Walgreens adds GLP-1 coverage navigation, Medicare Bridge support and pharmacist outreach to its virtual weight management ...
BMS’s Kevin Cook explains why digital capability is becoming a must-have for strategic CMO partners and why the next phase ...
Agentic AI is moving biopharma from tools that inform decisions to systems that execute them, reshaping discovery, clinical ...
In this week’s Pharma Pulse, GoodRx expands an employer offering built on manufacturer pricing for GLP-1 obesity drugs, a federal judge declines to block Lilly’s comparative Zepbound ads, and the PBM ...
Cencora’s Matt Sample and Gregg Gorniak explain why AI should recommend, not decide, and why pharma needs an agent strategy ...
FDA finalized guidance setting out how drug sponsors should label, describe and submit content from software used alongside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results